Danielle Golovin
Senior biopharma analyst at BioCentury who researches venture financing and Series A trends, presenting data-driven analysis of biotech startup funding.
Best podcasts with Danielle Golovin
Ranked by the Snipd community
25 snips
Feb 10, 2026 • 34min
Ep. 349 - Start-up Spotlight, Compounding Wegovy & Neuropysch
Selina Koch, neuroscience and psychiatry editor who interviews industry leaders. Steve Usdin, policy analyst focused on FDA and biomedical funding. Danielle Golovin, analyst tracking Series A and VC trends. They discuss 2025 Series A stabilization and which modalities drew funding. They debate how compounded Wegovy affects innovation and cover Congress defending NIH budgets. They explore serendipity versus engineering in psychiatric drug discovery.
